Dr. Kirti Chadha
Chief Scientific Officer
Sr Consultant Oncopathologist,
MD, PDCC (Oncopath & Oncohemat)
Metropolis Healthcare Ltd. Mumbai
Dr. Kirti Chadha is a gold medallist from Armed Forces Medical College in Pune, India. She has over two decades of rich experience in Diagnostics & Theranostics and is currently the Chief Scientific Officer at Metropolis Healthcare. Prior to Metropolis, she was previously associated with some of the renowned & leading hospitals in India.
Dr Kirti pioneered and established Digital Pathology for Metropolis in India and Africa and was instrumental in making Metropolis the 1st CAP & NABL accredited laboratory for WSI in India. She introduced the concept of Super Speciality pathology at Metropolis and had successfully launched Oncomet, Neurouno, Nephromet, Gynecxpert, Pediamet, Genomexpert, Gastromet, Microxpert, Histoxpert, Cardioxpert , Diabedge & Osteoxpert.
She curated the Research & Development, Academics & Innovation wing to enable Metropolis to become the 1st and best-in-class technology and test profiles for cost effective accurate diagnostics. She has been actively involved in forming a Medical Advisory Board by empanelling experts in the healthcare industry. With her valuable support and guidance, Metropolis has been successfully driving its prestigious CSR initiative ‘MedEngage’ - which extends scholarships, academic grants and research support for young doctors undergoing training.
Dr. Kirti is also on the WHO expert panel for Medical devices for cancer. She has delivered numerous orations on cancer across the country. She is also on the advisory board of Indian Cancer Society. She is a member of USCAP, IAPM, MPAI, ISHTM, APPI, GGP, ICON and IAP – ID.